Bruce W. Morlan

2.1k total citations
35 papers, 1.6k citations indexed

About

Bruce W. Morlan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Bruce W. Morlan has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Cancer Research. Recurrent topics in Bruce W. Morlan's work include Cardiac electrophysiology and arrhythmias (8 papers), ECG Monitoring and Analysis (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Bruce W. Morlan is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), ECG Monitoring and Analysis (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Bruce W. Morlan collaborates with scholars based in United States, Portugal and Canada. Bruce W. Morlan's co-authors include Karla V. Ballman, Robert F. Tarrell, Pedro J. Caraballo, J. Martijn Bos, Michael J. Ackerman, Lisa A. Boardman, Stephen N. Thibodeau, Shannon M. Dunlay, Kirsten Hall Long and Qian Shi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bruce W. Morlan

35 papers receiving 1.5k citations

Peers

Bruce W. Morlan

CCM

PRM

ONCOL

Jonathan D. Mosley United States

Christian Garbar France

Jie Wu China

Luigi Rossi Italy

Weijie Yuan China

Claudio Bilato Italy

Juan Li China

Baishen Pan China

Arno Lingenhel Austria

Fay Cafferty United Kingdom

Jonathan D. Mosley United States

Bruce W. Morlan

725 ×1.1

157 ×0.3

436 ×1.2

CCM

260 ×1.1

PRM

238 ×1.2

ONCOL

Citations per year, relative to Bruce W. Morlan Bruce W. Morlan (= 1×) peers Jonathan D. Mosley

Countries citing papers authored by Bruce W. Morlan

Since Specialization

Citations

This map shows the geographic impact of Bruce W. Morlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Morlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Morlan more than expected).

Fields of papers citing papers by Bruce W. Morlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Morlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Morlan. The network helps show where Bruce W. Morlan may publish in the future.

Co-authorship network of co-authors of Bruce W. Morlan

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce W. Morlan. A scholar is included among the top collaborators of Bruce W. Morlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce W. Morlan. Bruce W. Morlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malow, Beth A., et al.. (2022). Bridging the divide on climate solutions: Development, implementation, and evaluation of an online workshop for climate volunteers. SHILAP Revista de lepidopterología. 7. 100177–100177. 2 indexed citations

Bos, J. Martijn, Kristina H. Haugaa, Bruce W. Morlan, et al.. (2017). Prevalence and Outcome of High-Risk QT Prolongation Recorded in the Emergency Department from an Institution-Wide QT Alert System. Journal of Emergency Medicine. 54(1). 8–15. 18 indexed citations

Sharma, Sunita, J. Martijn Bos, Robert F. Tarrell, et al.. (2017). Providers’ Response to Clinical Decision Support for QT Prolonging Drugs. Journal of Medical Systems. 41(10). 161–161. 16 indexed citations

Joyce, Daniel, J. Martijn Bos, Kristina H. Haugaa, et al.. (2015). Frequency and Cause of Transient QT Prolongation After Surgery. The American Journal of Cardiology. 116(10). 1605–1609. 5 indexed citations

Romero‐Brufau, Santiago, Jeanne M. Huddleston, James M. Naessens, et al.. (2014). Widely used track and trigger scores: Are they ready for automation in practice?. Resuscitation. 85(4). 549–552. 45 indexed citations

Haugaa, Kristina H., J. Martijn Bos, Robert F. Tarrell, et al.. (2014). Impact of left ventricular hypertrophy on QT prolongation and associated mortality. Heart Rhythm. 11(11). 1957–1965. 14 indexed citations

Haugaa, Kristina H., J. Martijn Bos, Robert F. Tarrell, et al.. (2013). Institution-Wide QT Alert System Identifies Patients With a High Risk of Mortality. Mayo Clinic Proceedings. 88(4). 315–325. 128 indexed citations

Oberg, Ann L., Amy J. French, Aaron L. Sarver, et al.. (2011). miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer. PLoS ONE. 6(6). e20465–e20465. 117 indexed citations

Alberts, Steven R., Joel M. Reid, Bruce W. Morlan, et al.. (2011). Gemcitabine and Docetaxel for Hepatocellular Carcinoma. American Journal of Clinical Oncology. 35(5). 418–423. 14 indexed citations

10.

Alberts, Steven R., Tom R. Fitch, George P. Kim, et al.. (2011). Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma. American Journal of Clinical Oncology. 35(4). 329–333. 54 indexed citations

11.

Sinicrope, Frank A., Russell Broaddus, Eugene W. Gerner, et al.. (2011). Evaluation of Difluoromethylornithine for the Chemoprevention of Barrett's Esophagus and Mucosal Dysplasia. Cancer Prevention Research. 4(6). 829–839. 17 indexed citations

12.

Kitange, Gaspar J., Brett L. Carlson, Mark A. Schroeder, et al.. (2010). Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance. Journal of Neuro-Oncology. 100(2). 177–186. 43 indexed citations

13.

Kitange, Gaspar J., Thomas M. Kollmeyer, Mark E. Law, et al.. (2009). Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell‐mediated restoration of normal human chromosome 19. Genes Chromosomes and Cancer. 48(10). 854–864. 7 indexed citations

14.

Sarver, Aaron L., Amy J. French, Pedro M. Borralho, et al.. (2009). Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 9(1). 401–401. 266 indexed citations

15.

Cunningham, Julie M., Ann L. Oberg, Pedro M. Borralho, et al.. (2009). Evaluation of a new high-dimensional miRNA profiling platform. BMC Medical Genomics. 2(1). 57–57. 23 indexed citations

16.

McCollum, Andrea K., Cynthia J. TenEyck, Bridget Stensgard, et al.. (2008). P-Glycoprotein–Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock Response. Cancer Research. 68(18). 7419–7427. 57 indexed citations

17.

Nakagawa, Tohru, Thomas M. Kollmeyer, Bruce W. Morlan, et al.. (2008). A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy. PLoS ONE. 3(5). e2318–e2318. 135 indexed citations

18.

McWilliams, Robert R., Matthew P. Goetz, Bruce W. Morlan, et al.. (2007). Phase II Trial of Oxaliplatin/Irinotecan/5-Fluorouracil/Leucovorin for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 6(7). 516–521. 7 indexed citations

19.

Wilson, Marcia, et al.. (2006). Desmoid Tumors – a Characterization of Patients Seen at Mayo Clinic 1976–1999. Familial Cancer. 5(2). 191–194. 72 indexed citations

20.

Lindor, Noralane M., Jeff A. Sloan, Richard M. Goldberg, et al.. (2004). Colorectal Tumour Microsatellite Instability Test Results: Perspectives from Patients. Hereditary Cancer in Clinical Practice. 2(2). 69–75. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact